STOCK TITAN

Royalty Pharma officer plans $644K share sale

Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Royalty Pharma plc officer Terrance Coyne is named as the person for whose account 11,002 common shares are to be sold by TPC RP EPA1 LLC. The proposed sale is listed for August 13, 2026, at an aggregate market value of $644,277.12.

The shares were acquired from the issuer as compensation through performance awards on August 5, 2026. The sale is connected with a selling plan dated February 24, 2026, intended to comply with Rule 10b5-1(c). The past-three-months sales section lists TPC RP EPA1 LLC as selling 64,399 common shares on May 26, 2026, for gross proceeds of $3,476,118.96.

Common shares to be sold 11,002 shares Proposed sale listed for August 13, 2026
Aggregate market value $644,277.12 For the 11,002 common shares listed for sale
Common shares sold 64,399 shares TPC RP EPA1 LLC sale on May 26, 2026, listed under sales during the past 3 months
Gross proceeds $3,476,118.96 TPC RP EPA1 LLC sale on May 26, 2026
Rule 10b5-1(c) regulatory
"intended to comply with Rule 10b5-1(c)"
Rule 10b5-1(c) is an SEC guideline that lets company insiders set up a written, pre-planned schedule to buy or sell their company stock when they are not in possession of material, nonpublic information. For investors, it matters because such plans can reduce the appearance of insider trading by separating decisions from inside knowledge—like putting your trades on autopilot—while also requiring scrutiny since pre-planned trades can still affect market confidence and share value.
Performance Awards financial
"Acquired as compensation -- Performance Awards"
Aggregate Market Value financial
"Number of Shares or Other Units To Be Sold | Aggregate Market Value"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RPRX shares are proposed for sale, and what is their stated market value?

The notice lists 11,002 common shares for sale at an aggregate market value of $644,277.12, with an approximate sale date of August 13, 2026.

What recent RPRX share sales are listed for TPC RP EPA1 LLC?

The past-three-months sales section lists TPC RP EPA1 LLC as selling 64,399 common shares on May 26, 2026, for gross proceeds of $3,476,118.96.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading